Lion Biotechnologies to Participate in Upcoming Investor and Scientific Conferences
September 03, 2015 16:01 ET
|
Lion Biotechnologies, Inc.
NEW YORK, Sept. 3, 2015 (GLOBE NEWSWIRE) -- Lion Biotechnologies (Nasdaq:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor-infiltrating lymphocytes (TIL),...
Lion Biotechnologies Announces Strategic Hires
August 31, 2015 08:00 ET
|
Lion Biotechnologies, Inc.
NEW YORK, Aug. 31, 2015 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (Nasdaq:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor-infiltrating lymphocytes...
Lion Biotechnologies Announces Second Quarter 2015 Financial Results
August 10, 2015 16:00 ET
|
Lion Biotechnologies, Inc.
NEW YORK, Aug. 10, 2015 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (Nasdaq:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor-infiltrating lymphocytes...
Lion Biotechnologies to Join Russell Global Index
June 24, 2015 08:00 ET
|
Lion Biotechnologies, Inc.
LOS ANGELES, June 24, 2015 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (Nasdaq:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor-infiltrating lymphocytes...
Lion Biotechnologies Receives Orphan Drug Designation for LN-144 for the Treatment of Malignant Melanoma
June 10, 2015 12:00 ET
|
Lion Biotechnologies, Inc.
LOS ANGELES, June 10, 2015 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (Nasdaq:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor-infiltrating lymphocytes...
Lion Biotechnologies Names Molly Henderson Chief Financial Officer
June 08, 2015 08:00 ET
|
Lion Biotechnologies, Inc.
LOS ANGELES, June 8, 2015 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (Nasdaq:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor-infiltrating lymphocytes...
Lion Biotechnologies to Participate in Upcoming Investor Conferences
May 19, 2015 08:00 ET
|
Lion Biotechnologies, Inc.
LOS ANGELES, May 19, 2015 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (Nasdaq:LBIO) today announced that president and CEO Elma Hawkins, PhD, will participate in the following upcoming investor...
Lion Biotechnologies Announces Pricing of Secondary Offering of Shares by Selling Stockholders
May 01, 2015 08:45 ET
|
Lion Biotechnologies, Inc.
LOS ANGELES, May 1, 2015 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (Nasdaq:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor infiltrating lymphocytes,...
Lion Biotechnologies Announces Publication of Data From Clinical Study of Metastatic Cervical Cancer Patients Treated With HPV-TIL
April 08, 2015 08:26 ET
|
Lion Biotechnologies, Inc.
LOS ANGELES, April 8, 2015 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (Nasdaq:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor-infiltrating lymphocytes...
Lion Biotechnologies Announces Positive Data From a TIL-Ipilimumab Combination Study in Melanoma
March 30, 2015 06:00 ET
|
Lion Biotechnologies, Inc.
LOS ANGELES, March 30, 2015 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (Nasdaq:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor infiltrating...